Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Sanofi gets EC approval for Dupixent to treat severe asthma

asthma
The drug is being developed in multiple diseases driven by allergic and other Type 2 inflammation. Credit: BruceBlaus.